Vanguard Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Sell |
2,884,632
-375,980
| -12% | -$436K | ﹤0.01% | 3351 |
|
|
2025
Q1 | $5.18M | Sell |
3,260,612
-10,628
| -0.3% | -$16.9K | ﹤0.01% | 3157 |
|
|
2024
Q4 | $9.91M | Sell |
3,271,240
-1,341,467
| -29% | -$4.06M | ﹤0.01% | 2967 |
|
|
2024
Q3 | $17M | Sell |
4,612,707
-1,042,050
| -18% | -$3.83M | ﹤0.01% | 2669 |
|
|
2024
Q2 | $23.1M | Buy |
5,654,757
+1,256,132
| +29% | +$5.14M | ﹤0.01% | 2500 |
|
|
2024
Q1 | $69.3M | Sell |
4,398,625
-951,833
| -18% | -$15M | ﹤0.01% | 2033 |
|
|
2023
Q4 | $81.1M | Buy |
5,350,458
+113,795
| +2% | +$1.72M | ﹤0.01% | 1965 |
|
|
2023
Q3 | $105M | Buy |
5,236,663
+307,490
| +6% | +$6.17M | ﹤0.01% | 1784 |
|
|
2023
Q2 | $139M | Buy |
4,929,173
+688,558
| +16% | +$19.4M | ﹤0.01% | 1669 |
|
|
2023
Q1 | $72.9M | Buy |
4,240,615
+80,466
| +2% | +$1.38M | ﹤0.01% | 1984 |
|
|
2022
Q4 | $83.8M | Buy |
4,160,149
+53,888
| +1% | +$1.09M | ﹤0.01% | 1901 |
|
|
2022
Q3 | $88.9M | Sell |
4,106,261
-386,074
| -9% | -$8.36M | ﹤0.01% | 1858 |
|
|
2022
Q2 | $126M | Buy |
4,492,335
+1,251,750
| +39% | +$35.2M | ﹤0.01% | 1681 |
|
|
2022
Q1 | $150M | Buy |
3,240,585
+53,599
| +2% | +$2.47M | ﹤0.01% | 1730 |
|
|
2021
Q4 | $268M | Buy |
3,186,986
+55,101
| +2% | +$4.63M | 0.01% | 1424 |
|
|
2021
Q3 | $209M | Buy |
3,131,885
+297,061
| +10% | +$19.8M | 0.01% | 1579 |
|
|
2021
Q2 | $151M | Buy |
2,834,824
+415,976
| +17% | +$22.1M | ﹤0.01% | 1783 |
|
|
2021
Q1 | $105M | Buy |
2,418,848
+72,711
| +3% | +$3.15M | ﹤0.01% | 1919 |
|
|
2020
Q4 | $122M | Buy |
2,346,137
+1,212,170
| +107% | +$63M | ﹤0.01% | 1735 |
|
|
2020
Q3 | $37.1M | Buy |
1,133,967
+307,025
| +37% | +$10M | ﹤0.01% | 2165 |
|
|
2020
Q2 | $39.7M | Buy |
+826,942
| New | +$39.7M | ﹤0.01% | 2118 |
|